---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-20T14:57:14.808640'
end_time: '2026-02-20T15:06:53.152379'
duration_seconds: 578.34
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: HSPA1B
  gene_symbol: HSPA1B
  uniprot_accession: P0DMV9
  protein_description: 'RecName: Full=Heat shock 70 kDa protein 1B {ECO:0000312|HGNC:HGNC:5233};
    AltName: Full=Heat shock 70 kDa protein 2; Short=HSP70-2 {ECO:0000303|PubMed:14656967,
    ECO:0000303|PubMed:2538825}; Short=HSP70.2; AltName: Full=Heat shock protein family
    A member 1B;'
  gene_info: Name=HSPA1B {ECO:0000312|HGNC:HGNC:5233}; Synonyms=HSP72 {ECO:0000303|PubMed:24318877};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the heat shock protein 70 family. .
  protein_domains: ATPase_NBD. (IPR043129); Heat_shock_70_CS. (IPR018181); HSP70_C_sf.
    (IPR029048); HSP70_peptide-bd_sf. (IPR029047); Hsp_70_fam. (IPR013126)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 17
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P0DMV9
- **Protein Description:** RecName: Full=Heat shock 70 kDa protein 1B {ECO:0000312|HGNC:HGNC:5233}; AltName: Full=Heat shock 70 kDa protein 2; Short=HSP70-2 {ECO:0000303|PubMed:14656967, ECO:0000303|PubMed:2538825}; Short=HSP70.2; AltName: Full=Heat shock protein family A member 1B;
- **Gene Information:** Name=HSPA1B {ECO:0000312|HGNC:HGNC:5233}; Synonyms=HSP72 {ECO:0000303|PubMed:24318877};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the heat shock protein 70 family. .
- **Key Domains:** ATPase_NBD. (IPR043129); Heat_shock_70_CS. (IPR018181); HSP70_C_sf. (IPR029048); HSP70_peptide-bd_sf. (IPR029047); Hsp_70_fam. (IPR013126)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "HSPA1B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'HSPA1B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **HSPA1B** (gene ID: HSPA1B, UniProt: P0DMV9) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P0DMV9
- **Protein Description:** RecName: Full=Heat shock 70 kDa protein 1B {ECO:0000312|HGNC:HGNC:5233}; AltName: Full=Heat shock 70 kDa protein 2; Short=HSP70-2 {ECO:0000303|PubMed:14656967, ECO:0000303|PubMed:2538825}; Short=HSP70.2; AltName: Full=Heat shock protein family A member 1B;
- **Gene Information:** Name=HSPA1B {ECO:0000312|HGNC:HGNC:5233}; Synonyms=HSP72 {ECO:0000303|PubMed:24318877};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the heat shock protein 70 family. .
- **Key Domains:** ATPase_NBD. (IPR043129); Heat_shock_70_CS. (IPR018181); HSP70_C_sf. (IPR029048); HSP70_peptide-bd_sf. (IPR029047); Hsp_70_fam. (IPR013126)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "HSPA1B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'HSPA1B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **HSPA1B** (gene ID: HSPA1B, UniProt: P0DMV9) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Title: Functional Annotation Research Report — Human HSPA1B (HSP70-2; UniProt P0DMV9)

Publication focus: 2023–2024 (with limited supplementation from 2025 where necessary for general Hsp70 background).

1. Target identity verification (critical disambiguation)

1.1. Gene/protein and organism
HSPA1B is the human (Homo sapiens) stress-inducible HSP70-family member commonly referred to as “HSP70-2”. A 2023 review tabulates HSPA1B as “HSP70-2”, localized to cytosol/nucleus (and also described as present in exosomes) and located at 6p21.3, alongside the closely related paralogs HSPA1A (“HSP70-1”) and HSPA1L (“HSP70-1L”). https://doi.org/10.3390/biom13040604 (published Mar 2023) (mouawad2023isitstill pages 2-4)

A separate 2023 source explicitly lists HspA1B (Heat shock 70 kDa protein 1B) with UniProt accession P0DMV9, and differentiates related family members HspA1A (P0DMV8) and HspA1L (P34931). This supports that the UniProt target in the prompt (P0DMV9) corresponds to HSPA1B. (grey2023theregulationof pages 105-108)

1.2. Practical implication for literature use
A recurrent issue in the literature is isoform ambiguity: many papers refer generically to “HSP70/Hsp70/HSP72” without resolving HSPA1A vs HSPA1B, and some mechanistic findings (especially on extracellular HSP70) likely apply to multiple inducible HSP70 paralogs rather than uniquely to HSPA1B. Where the evidence is isoform-explicit, this report labels it as HSPA1B-specific; otherwise, it is described as “inducible HSP70 family” evidence. (mouawad2023isitstill pages 2-4, rodrigueziturbe2023hsp70andprimary pages 1-2)

2. Key concepts, definitions, and current mechanistic understanding

2.1. Molecular function: ATP-dependent molecular chaperone
HSPA1B belongs to the HSP70 family of molecular chaperones. Core function is maintenance of proteostasis via binding to exposed hydrophobic segments of client proteins and supporting folding/refolding and quality control. A 2023 review describes HspA1A and HspA1B as major stress-inducible HSP70s and places them within a broader HSP70 family that supports protein homeostasis and stress adaptation. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

2.2. Domain architecture (functional definition of “HSP70”)
Authoritative 2023–2024 reviews describe the conserved HSP70 architecture as:
• N-terminal nucleotide-binding domain (NBD; ATPase) that binds and hydrolyzes ATP
• C-terminal substrate-binding domain (SBD) that engages client polypeptides
• C-terminal tail that mediates co-chaperone interactions (e.g., with BAG proteins).
This tripartite organization is explicitly summarized in a 2023 review. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

A 2024 cancer-focused review similarly summarizes HSP70 as having an N-terminal NBD and a C-terminal SBD underpinning its chaperone function. https://doi.org/10.3389/fonc.2024.1388999 (published Apr 2024) (hu2024diversityofextracellular pages 1-2)

2.3. Chaperone cycle and co-chaperone dependence
Inducible HSP70 activity is described as ATP-dependent and strongly co-chaperone-dependent:
• HSP40/DnaJ co-chaperones stimulate HSP70 ATP hydrolysis and assist substrate recognition/processing.
• HSP70 cooperates with HSP90 in client maturation pathways.
These mechanistic concepts are described in a 2023 review of HSP70 in hypertension and immunity. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

2.4. Subcellular localization under basal vs stress conditions
Intracellular localization: HSPA1B is described as a cytosolic/nuclear inducible HSP70, while the broader family spans cytosol, nucleus, mitochondria, and ER. https://doi.org/10.3390/biom13040604 (published Mar 2023) (mouawad2023isitstill pages 2-4)

Stress response magnitude: A 2023 review notes that stress-induced HSP70 expression can rise to extremely high levels, reported up to ~15% of cellular protein under stress. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

3. Recent developments (2023–2024) and latest research emphasis

3.1. Extracellular HSP70 (eHSP70) diversity and trafficking (2024 synthesis)
A major 2024 review advances the concept that HSP70 (including HSPA1B among the membrane/exosomal HSP70s) is not restricted to intracellular compartments: it can appear on the plasma membrane or be released extracellularly as free soluble protein and/or within extracellular vesicles (EVs), including exosomes. The review explicitly lists HSPA1B among HSP70 family members reported on the plasma membrane and in exosomes. https://doi.org/10.3389/fonc.2024.1388999 (published Apr 2024) (hu2024diversityofextracellular pages 1-2)

Mechanistic features highlighted in 2024 include:
• Membrane insertion and affinity for negatively charged phospholipids, especially phosphatidylserine (PS)
• Oligomerization coupled to PS binding, facilitating membrane association
• Enrichment in lipid rafts and interaction with globotriaosylceramide (Gb3)
These are described in the 2024 review, providing a current conceptual model for membrane HSP70 biology in cancer contexts. https://doi.org/10.3389/fonc.2024.1388999 (published Apr 2024) (hu2024diversityofextracellular pages 1-2)

3.2. Active secretion routes and EV pathways; PTM/oligomerization as determinants
The same 2024 review emphasizes that extracellular appearance is often active (non-classical secretion), citing multiple routes:
• Export via secretory-like granules
• Translocation into endolysosomes via ATP-binding cassette (ABC) transporters followed by fusion with the plasma membrane
• Release via exocytosis of exosomes or plasma-membrane budding (ectosomes)
It also notes that post-translational modifications (PTMs) and oligomerization can influence HSP70 loading into exosomes. https://doi.org/10.3389/fonc.2024.1388999 (published Apr 2024) (hu2024diversityofextracellular pages 2-4)

Figure-based evidence: A graphical summary figure from this 2024 review schematizes the three major extracellular states of HSP70 (membrane-associated, EV-associated, soluble) and the secretion/translocation pathways described above. (hu2024diversityofextracellular media 859e9929)

3.3. Cell-surface epitope and antibody-based detectability (2023 synthesis)
A 2023 onco-hematology review highlights an operationally important concept: membrane-localized inducible HSP70 exposes a defined extracellular peptide epitope (“TKD”, sequence TKDNNLLGRFELSG; aa450–461) detectable by the monoclonal antibody cmHSP70.1. This supports real-world measurement strategies for membrane HSP70 positivity (often discussed at the inducible HSP70 level, not always isoform-resolved). https://doi.org/10.3390/biom13040604 (published Mar 2023) (mouawad2023isitstill pages 2-4)

4. Biological processes, pathways, and functional roles (evidence-weighted)

4.1. Proteostasis and stress adaptation
Inducible HSP70 proteins (including HSPA1B) are positioned as central stress-response effectors supporting refolding of damaged proteins and preventing aggregation, with downstream consequences for survival under physiological and environmental stress. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

4.2. Apoptosis and inflammatory signaling modulation
A 2023 review summarizes that HSP70 induction can inhibit apoptosis and suppress inflammatory pathways, including inhibition of Bax mitochondrial translocation as an example mechanism in anti-apoptotic activity (presented at the inducible HSP70 level). https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

4.3. Immune-related extracellular functions (cytokine-like roles)
Extracellular HSP70 is described as having immunomodulatory functions: it can be found complexed to antigenic peptides, present in exosomes, or as soluble protein; it can assist antigen transit to MHC in antigen-presenting cells and can drive tolerogenic or pro-inflammatory/autoimmune responses depending on context. https://doi.org/10.3390/biom13020272 (published Feb 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2)

5. Current applications and real-world implementations (with quantitative statistics)

5.1. Biomarker/diagnostic feature: E. coli sepsis transcriptomics (2023)
A 2023 Diagnostics study identified HSPA1B as an E. coli infection–specific hub gene and validated its diagnostic performance in an external dataset (GSE6269), reporting ROC-AUC = 0.7038 for HSPA1B (TNF ROC-AUC = 0.7116). https://doi.org/10.3390/diagnostics13233542 (published Nov 2023) (shao2023escherichiacoliinfection pages 1-2)

Interpretation: This supports potential use of HSPA1B expression as part of multi-gene classifiers for pathogen-specific sepsis characterization, though AUC indicates moderate discrimination and would require prospective validation. (shao2023escherichiacoliinfection pages 1-2)

5.2. Clinical tissue expression in inflammatory vulvar dermatoses (2023)
A 2023 study quantified HSPA1B expression in vulvar tissue:
• Controls: 6.54 ± 3.41
• Lichen sclerosus (LS): 9.94 ± 6.88
• Lichen planus (LP): 9.43 ± 2.31
The authors report HSPA1A/HSPA1B expression tends to be higher in LS/LP versus controls, but in this dataset HSPA1B differences did not reach statistical significance, and HSPA1A and HSPA1B were strongly correlated (Rs = 0.74; p = 0.00). https://doi.org/10.5603/gp.a2023.0011 (published Feb 2023) (marzec2023expressionofheat pages 1-2, marzec2023expressionofheat pages 2-3)

Interpretation: This provides real-world quantitative expression data supporting stress-response chaperone activation in chronic inflammatory tissue settings, while also illustrating that HSPA1B-specific signals may be subtle in small cohorts. (marzec2023expressionofheat pages 2-3)

5.3. Oncology: extracellular HSP70 as biomarker/target (2024)
A 2024 review frames extracellular HSP70 (including HSPA1B among isoforms detected in membrane/exosomal compartments) as a tumor biomarker and a therapeutic target candidate, because extracellular HSP70 associates with cancer-related processes (proliferation, apoptosis balance, ECM remodeling, EMT, angiogenesis) and treatment resistance (chemo-/radio-/anti-PD-1) in the compiled literature. https://doi.org/10.3389/fonc.2024.1388999 (published Apr 2024) (hu2024diversityofextracellular pages 1-2)

5.4. Therapeutic targeting considerations (expert synthesis, 2023)
A 2023 onco-hematology review provides an expert, critical assessment: despite extensive preclinical work positioning HSP70 as highly cytoprotective and implicated in poor prognosis and therapy resistance, “HSP70 inhibitors never reached the clinic” (as of the review). The review also highlights indirect strategies targeting HSP70 partners such as HSF1 or co-chaperones as alternative angles. https://doi.org/10.3390/biom13040604 (published Mar 2023) (mouawad2023isitstill pages 2-4)

6. Expert opinion and consensus themes (authoritative analyses)

6.1. Consensus on inducible HSP70s (HSPA1A/HSPA1B) as core stress-response chaperones
Two independent 2023 reviews (hypertension/immunity; onco-hematology) converge on the view that HSPA1A and HSPA1B are major stress-inducible HSP70 proteins with central roles in proteostasis, survival signaling, and immune modulation, and that these inducible HSP70s can be present in cytosol/nucleus and extracellularly (including exosomes). https://doi.org/10.3390/biom13020272 (Feb 2023); https://doi.org/10.3390/biom13040604 (Mar 2023) (rodrigueziturbe2023hsp70andprimary pages 1-2, mouawad2023isitstill pages 2-4)

6.2. Emerging consensus on extracellular trafficking as regulated (not merely leakage)
The 2024 synthesis emphasizes that extracellular HSP70 is often actively trafficked through specific pathways (EVs, nonclassical secretion) and that membrane association involves specific lipid interactions and microdomain partitioning, aligning extracellular HSP70 biology with regulated intercellular signaling rather than only necrotic release. https://doi.org/10.3389/fonc.2024.1388999 (Apr 2024) (hu2024diversityofextracellular pages 2-4, hu2024diversityofextracellular pages 1-2)

7. Limitations of current evidence for HSPA1B-specific functional annotation

7.1. Isoform resolution
Many mechanistic claims in the 2023–2024 literature are at “HSP70” or “inducible HSP70” resolution rather than explicitly HSPA1B, and the reviewed evidence indicates shared features among HSPA1A/HSPA1B/HSPA1L in localization and extracellular trafficking. Accordingly, the most defensible HSPA1B-specific statements from the retrieved evidence are: (i) identity mapping to UniProt P0DMV9 and (ii) localization being cytosol/nucleus and (also reported) exosomes. (grey2023theregulationof pages 105-108, mouawad2023isitstill pages 2-4)

7.2. PTMs and pathway membership
The 2024 review notes PTMs influence exosome loading of HSP70, but does not specify HSPA1B site-level modifications in the retrieved excerpt. Therefore, this report cannot provide a confident residue-specific PTM annotation for HSPA1B based on the available 2023–2024 evidence corpus here. (hu2024diversityofextracellular pages 2-4)

8. Key references (URLs and publication dates)

• Hu B, Liu G, Zhao K, Zhang G. “Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target.” Frontiers in Oncology. Published Apr 2024. https://doi.org/10.3389/fonc.2024.1388999 (hu2024diversityofextracellular pages 1-2, hu2024diversityofextracellular pages 2-4, hu2024diversityofextracellular media 859e9929)

• Rodriguez-Iturbe B, Johnson RJ, Sanchez-Lozada LG, Pons H. “HSP70 and Primary Arterial Hypertension.” Biomolecules. Published Feb 2023. https://doi.org/10.3390/biom13020272 (rodrigueziturbe2023hsp70andprimary pages 1-2)

• Mouawad N, et al. “Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?” Biomolecules. Published Mar 2023. https://doi.org/10.3390/biom13040604 (mouawad2023isitstill pages 2-4)

• Shao Q, et al. “Escherichia coli Infection Sepsis: An Analysis of Specifically Expressed Genes and Clinical Indicators.” Diagnostics. Published Nov 2023. https://doi.org/10.3390/diagnostics13233542 (shao2023escherichiacoliinfection pages 1-2)

• Marzec A, et al. “Expression of heat shock proteins HSPA1A, HSPA1B and TP53 in vulval lichen planus and vulval lichen sclerosus.” Ginekologia Polska. Published Feb 2023. https://doi.org/10.5603/gp.a2023.0011 (marzec2023expressionofheat pages 1-2, marzec2023expressionofheat pages 2-3)

• Grey GS. (2023) Table-based UniProt mapping for human HspA1B = P0DMV9 and related paralogs. (Note: source metadata incomplete in retrieval; use cautiously for conclusions beyond accession mapping.) (grey2023theregulationof pages 105-108)

Figure cited
• Graphical summary of extracellular HSP70 trafficking states/routes (membrane-associated, EV-associated, soluble secretion/necrosis) from Hu et al., 2024. (hu2024diversityofextracellular media 859e9929)

References

1. (mouawad2023isitstill pages 2-4): Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, and Federica Frezzato. Is it still possible to think about hsp70 as a therapeutic target in onco-hematological diseases? Biomolecules, 13:604, Mar 2023. URL: https://doi.org/10.3390/biom13040604, doi:10.3390/biom13040604. This article has 19 citations.

2. (grey2023theregulationof pages 105-108): GS Grey. The regulation of the hsp70 family molecular chaperone bip via phosphorylation. Unknown journal, 2023.

3. (rodrigueziturbe2023hsp70andprimary pages 1-2): Bernardo Rodriguez-Iturbe, Richard J. Johnson, Laura Gabriela Sanchez-Lozada, and Hector Pons. Hsp70 and primary arterial hypertension. Biomolecules, 13:272, Feb 2023. URL: https://doi.org/10.3390/biom13020272, doi:10.3390/biom13020272. This article has 26 citations.

4. (hu2024diversityofextracellular pages 1-2): Binbin Hu, Guihong Liu, Kejia Zhao, and Gao Zhang. Diversity of extracellular hsp70 in cancer: advancing from a molecular biomarker to a novel therapeutic target. Frontiers in Oncology, Apr 2024. URL: https://doi.org/10.3389/fonc.2024.1388999, doi:10.3389/fonc.2024.1388999. This article has 24 citations.

5. (hu2024diversityofextracellular pages 2-4): Binbin Hu, Guihong Liu, Kejia Zhao, and Gao Zhang. Diversity of extracellular hsp70 in cancer: advancing from a molecular biomarker to a novel therapeutic target. Frontiers in Oncology, Apr 2024. URL: https://doi.org/10.3389/fonc.2024.1388999, doi:10.3389/fonc.2024.1388999. This article has 24 citations.

6. (hu2024diversityofextracellular media 859e9929): Binbin Hu, Guihong Liu, Kejia Zhao, and Gao Zhang. Diversity of extracellular hsp70 in cancer: advancing from a molecular biomarker to a novel therapeutic target. Frontiers in Oncology, Apr 2024. URL: https://doi.org/10.3389/fonc.2024.1388999, doi:10.3389/fonc.2024.1388999. This article has 24 citations.

7. (shao2023escherichiacoliinfection pages 1-2): Qingyi Shao, Danlei Chen, Simiao Chen, Xuanwen Ru, and Qing Ye. Escherichia coli infection sepsis: an analysis of specifically expressed genes and clinical indicators. Diagnostics, 13:3542, Nov 2023. URL: https://doi.org/10.3390/diagnostics13233542, doi:10.3390/diagnostics13233542. This article has 20 citations.

8. (marzec2023expressionofheat pages 1-2): Adrianna Marzec, Aleksandra Augusciak-Duma, Dominika Kupny-Bujoczek, Lukasz Witek, Anita Olejek, and Iwona Gabriel. Expression of heat shock proteins hspa1a, hspa1b and tp53 in vulval lichen planus and vulval lichen sclerosus. Ginekologia polska, Feb 2023. URL: https://doi.org/10.5603/gp.a2023.0011, doi:10.5603/gp.a2023.0011. This article has 2 citations and is from a peer-reviewed journal.

9. (marzec2023expressionofheat pages 2-3): Adrianna Marzec, Aleksandra Augusciak-Duma, Dominika Kupny-Bujoczek, Lukasz Witek, Anita Olejek, and Iwona Gabriel. Expression of heat shock proteins hspa1a, hspa1b and tp53 in vulval lichen planus and vulval lichen sclerosus. Ginekologia polska, Feb 2023. URL: https://doi.org/10.5603/gp.a2023.0011, doi:10.5603/gp.a2023.0011. This article has 2 citations and is from a peer-reviewed journal.

## Citations

1. mouawad2023isitstill pages 2-4
2. grey2023theregulationof pages 105-108
3. hu2024diversityofextracellular pages 1-2
4. hu2024diversityofextracellular pages 2-4
5. shao2023escherichiacoliinfection pages 1-2
6. marzec2023expressionofheat pages 2-3
7. marzec2023expressionofheat pages 1-2
8. https://doi.org/10.3390/biom13040604
9. https://doi.org/10.3390/biom13020272
10. https://doi.org/10.3389/fonc.2024.1388999
11. https://doi.org/10.3390/diagnostics13233542
12. https://doi.org/10.5603/gp.a2023.0011
13. https://doi.org/10.3390/biom13040604,
14. https://doi.org/10.3390/biom13020272,
15. https://doi.org/10.3389/fonc.2024.1388999,
16. https://doi.org/10.3390/diagnostics13233542,
17. https://doi.org/10.5603/gp.a2023.0011,